Document Detail

Long-term evolution of gut inflammation in patients with spondyloarthropathy.
MedLine Citation:
PMID:  8964393     Owner:  NLM     Status:  MEDLINE    
BACKGROUND & AIMS: Intestinal inflammation has been observed in patients with spondyloarthropathy (SpA). This prospective study reports the evolution of the intestinal inflammation observed in patients with SpA. METHODS: One hundred twenty-three patients with SpA who had undergone initial endoscopy were clinically reassessed. Intestinal evolution was evaluated by ileocolonoscopy and the histological study of biopsy specimens in 49 patients. RESULTS: Articular remission rates were independent of initial gut inflammation and associated with endoscopic and histological remission. Persistent gut inflammation was observed in active joint disease. Gut inflammation rarely disappeared, despite the persistence of articular complaints. Initial chronic gut inflammation implied a high risk of evolution to ankylosing spondylitis. Evolution to inflammatory bowel disease (IBD) was observed in 7% of patients. Mainly patients with initial chronic inflammation and mild complaints of diarrhea were at risk. Sulfasalazine was more frequently needed in the treatment of patients with gut inflammation with a beneficial effect on articular and intestinal evolution but did not prevent evolution to IBD. CONCLUSIONS: This study supports the etiopathogenetic role of the gut in SpA. Presence of chronic gut inflammation and mild complaints of diarrhea implies a high risk of evolution to ankylosing spondylitis and IBD. Sulfasalazine has a beneficial effect on articular activity by controlling gut inflammation, but it cannot prevent evolution to overt IBD.
M De Vos; H Mielants; C Cuvelier; A Elewaut; E Veys
Related Documents :
21480833 - N-terminal-pro-bnp in critically ill patients with acute respiratory failure: a prospec...
20840373 - Intestinal epithelial cell proliferation, apoptosis and expression of tight junction pr...
1267583 - Wheelchair cushions designed to prevent pressure sores: an evaluation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gastroenterology     Volume:  110     ISSN:  0016-5085     ISO Abbreviation:  Gastroenterology     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-12-12     Completed Date:  1996-12-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1696-703     Citation Subset:  AIM; IM    
Department of Gastroenterology, University Hospital Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Disease Progression
Enteritis / etiology*,  pathology,  physiopathology
Follow-Up Studies
Longitudinal Studies
Middle Aged
Prospective Studies
Spinal Diseases / complications*,  drug therapy,  physiopathology
Sulfasalazine / therapeutic use
Treatment Outcome
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 599-79-1/Sulfasalazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity.
Next Document:  A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile ...